Overcoming the Tumor Collagen Barriers: A Multistage Drug Delivery Strategy for DDR1‐Mediated Resistant Colorectal Cancer Therapy
Advanced Science · 2024-09 · 11 (33)
DOI: 10.1002/advs.202402107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 02.07.2024. Verfasst von Guangman Cui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medi…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Discoidin Domain Receptor 1, Drug Resistance, Neoplasm, Drug Delivery Systems. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Cancer, Guangdong Provincial Major Talents Project.
Abstract (Originalsprache)
The extracellular matrix (ECM) is critical for drug resistance in colorectal cancer (CRC). The abundant collagen within the ECM significantly influences tumor progression and matrix‐mediated drug resistance (MMDR) by binding to discoidin domain receptor 1 (DDR1), but the specific mechanisms by which tumor cells modulate ECM via DDR1 and ultimately regulate TME remain poorly understand. Furthermore, overcoming drug resistance by modulating the tumor ECM remains a challenge in CRC treatment. In this study, a novel mechanism is elucidated by which DDR1 mediates the interactions between tumor cells and collagen, enhances collagen barriers, inhibits immune infiltration, promotes drug efflux, and leads to MMDR in CRC. To address this issue, a multistage drug delivery system carrying DDR1‐siRNA and chemotherapeutic agents is employed to disrupt collagen barriers by silencing DDR1 in tumor, enhancing chemotherapy drugs diffusion and facilitating immune infiltration. These findings not only revealed a novel role for collagen‐rich matrix mediated by DDR1 in tumor resistance, but also introduced a promising CRC treatment strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
- The Tenth Affiliated Hospital of Southern Medical University, Dongguan, Guangdong, 523059, China.
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical…
- Breast Center, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
- Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.
- Department of Gastrointestinal Surgery, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, 5…
ORCID-Profile: Jun Yan
Förderung
- National Natural Science Foundation of China
- Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Cancer
- Guangdong Provincial Major Talents Project
- Natural Science Foundation of Guangdong Province
- Guangdong Basic and Applied Basic Research Foundation
- Science and Technology Planning Project of Guangzhou City
- China Postdoctoral Science Foundation
- Clinical Research Project of Nanfang Hospital
Zitieren
APA
Cui, G., Deng, S., Zhang, B., Wang, M., Lin, Z., Lan, X., Li, Z., Yao, G., Yu, M., & Yan, J. (2024). Overcoming the Tumor Collagen Barriers: A Multistage Drug Delivery Strategy for DDR1‐Mediated Resistant Colorectal Cancer Therapy. Advanced Science, 11(33). https://doi.org/10.1002/advs.202402107
Vancouver
Cui G, Deng S, Zhang B, Wang M, Lin Z, Lan X, et al. Overcoming the Tumor Collagen Barriers: A Multistage Drug Delivery Strategy for DDR1‐Mediated Resistant Colorectal Cancer Therapy. Advanced Science. 2024;11(33). doi:10.1002/advs.202402107
BibTeX
@article{Cui2024,
author = {Cui, Guangman and Deng, Shaohui and Zhang, Biao and Wang, Manchun and Lin, Zhousheng and Lan, Xinyue and Li, Zelong and Yao, Guangyu and Yu, Meng and Yan, Jun},
title = {Overcoming the Tumor Collagen Barriers: A Multistage Drug Delivery Strategy for DDR1‐Mediated Resistant Colorectal Cancer Therapy},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {33},
doi = {10.1002/advs.202402107}
}
EUVIMED